Tamei Elliott, MS, is the Director of Global Scientific Content at the Drug Information Association (DIA). She leads DIA’s global scientific content strategy, ensuring alignment with regulatory priorities, industry trends, and evolving stakeholder needs across regions. She also established and leads DIA’s Global Science Content Center of Excellence, driving harmonization of content development and strategy across Europe, Asia, North Africa, and the Middle East. With expertise in regulatory science, she brings stakeholders together to address the life sciences industry’s most pressing challenges, driving outcomes that move toward solutions.

Twyla Mosey, PharmD, RPh is the Acting Director of the Office of Prescription Drug Promotion (OPDP) at the Food and Drug Administration. She ensures that OPDP fulfills its mission of protecting the public health by overseeing office operations including compliance activities, advisory and labeling recommendations, and external outreach activities. Over the past 18 years, Twyla has held various leadership roles within the Agency and pharmaceutical industry. She received her Doctor of Pharmacy degree from Florida Agricultural and Mechanical University and completed several fellowships including a Post-Doctoral Pharmaceutical Industry Fellowship.